Eurofins STA Laboratories (ESTA) and Eurofins BioDiagnostics have merged into a single company and brand.
By combining the analytical and genetic service strengths of EBDI with the extensive experience of ESTA in the seed and plant health arena, this new entity becomes the most complete analytical testing company in North America focused on the seed, plant, and agbio testing markets, the companies said in a statement.
The combined company will maintain the name of Eurofins BioDiagnostics. The consolidated portfolio of assays provides an unparalleled suite of testing services for the seed and plant industries, from germination testing to disease resistance screening to grapevine plant disease diagnosis to genetic fingerprinting to testing a wide range of seed pathogens for many different crop species, and many other analytical testing services.
Commenting on the merger, Michael Drozd, President of the Eurofins BioDiagnostics said, “Although there is significant brand recognition and loyalty in the Eurofins STA brand, we believe that the name BioDiagnostics better captures our broader vision for the future of the company. The Eurofins BioDiagnostics brand signifies diagnostic discovery and innovation for the global agricultural biological market. At the same time, our constant commitment to providing the highest level of customer service and quality will not change, and we are excited to be able to serve our valued customers with the most complete offering of services for seed and plant testing in the industry.”
